🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A clinical study to determine the safety, efficacy and the way sitagliptin ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-14
Trial ID
NCT00704132
Treatments Being Tested
Over the years, numbers of cardioprotective drugs have been evaluated to at...
Status
Unknown
Location
Kyung Hee University Hospital
Start Date
2015-02
Trial ID
NCT02406950
Treatments Being Tested
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
To compare the effect on glycemic control (HbA1c) of exenatide suspension a...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01652729
Treatments Being Tested
The purpose of this study is to determine if albiglutide is safe and effect...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00838903
This study will test the effectiveness and safety of treatment with MK-0893...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00631488
Treatments Being Tested
This is a Phase I, first-in-human, randomised, double-blinded, placebo-and ...
Status
Unknown
Location
Parexel International GmbH Early Phase Clinical Unit Klinikum Westend
Start Date
2021-07-07
Trial ID
NCT04982705
The present study is a phase I, single-centre, double-blind, randomized, cr...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2011-11
Trial ID
NCT02749032
Treatments Being Tested
The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02025907
Treatments Being Tested
This is a multiple dose study to evaluate the safety, tolerability, PK, and...
Status
Completed
Location
ProSciento, Inc.
Start Date
2022-09-21
Trial ID
NCT05900531